Abbott India Limited (NSE:ABBOTINDIA)
27,945
+425 (1.54%)
May 15, 2026, 3:29 PM IST
Abbott India Revenue
In the fiscal year ending March 31, 2026, Abbott India had annual revenue of 72.17B INR with 12.61% growth. Abbott India had revenue of 17.85B in the quarter ending March 31, 2026, with 11.25% growth.
Revenue
72.17B
Revenue Growth
+12.61%
P/S Ratio
8.22
Revenue / Employee
19.72M
Employees
3,659
Market Cap
593.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 72.17B | 8.08B | 12.61% |
| Mar 31, 2025 | 64.09B | 5.60B | 9.58% |
| Mar 31, 2024 | 58.49B | 5.00B | 9.35% |
| Mar 31, 2023 | 53.49B | 4.35B | 8.86% |
| Mar 31, 2022 | 49.13B | 6.03B | 14.00% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aurobindo Pharma | 331.82B |
| Cipla | 277.12B |
| Zydus Lifesciences | 260.89B |
| Glenmark Pharmaceuticals | 165.10B |
| Alkem Laboratories | 142.53B |
| Mankind Pharma | 139.14B |
| Ipca Laboratories | 95.06B |
| Emcure Pharmaceuticals | 92.04B |
Abbott India News
- 2 months ago - Pharma sector stocks today, March 12: Divi's Laboratories down 1.87%, Abbott India drops 1.51%, Aarti Drugs falls 1.36% - Business Upturn
- 1 year ago - Abbott India shares surge 3% as net profit jumps 16% YoY to Rs 360.8 crore in Q3 - Business Upturn
- 1 year ago - Pharma stocks: Glenmark up 1.57%, Glaxo gains 1.31%, Mankind Pharma declines 2.84% - Business Upturn
- 1 year ago - Pharma Stocks Today: Biocon surges 4.41%, Mankind Pharma up 1.85%; Glaxo and Abbott India decline - Business Upturn
- 1 year ago - Stock Market Update, January 7: Apollo Hospitals, Apar Industries, Abbott India, Amber Enterprises and more hit 52-week highs today - Business Upturn
- 1 year ago - Pharma Stocks: Cipla down nearly 2%, Ajanta Pharma down 1.45%, Abbott India up 1.27% - Business Upturn
- 1 year ago - Abbott India launches 14-Valent Pneumococcal Conjugate vaccine offering broad protection for children - Business Upturn
- 1 year ago - Abbott India shares fall nearly 4% following Q2 results - Business Upturn